Disrupt PAD III trial demonstrates safety and effectiveness of intravascular lithotripsy for peripheral artery calcification
One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to percutaneous…